Vanda Pharmaceuticals Limited
Registered name: VANDA PHARMACEUTICALS LIMITED
Part of Vanda Pharmaceuticals Inc. groupVanda Pharmaceuticals Limited made £920k revenue and £29.3k profit in the year to 31 Dec 2024.
Vanda Pharmaceuticals Limited’s revenue grew 35% to £920k in the year to 31 Dec 2024, with £29.3k profit and 3 employees. The company is classified under “other research and experimental development on natural sciences and engineering” and is based in London; we hold 2 years of its filed accounts.
- Status
- Active
- Location
- London, London
- Age
- 16 yrs · since 2010
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2023 | 31 Dec 2024 |
|---|---|---|
| Disclosure | Full P&L | Full P&L |
| Profit & loss | ||
| Revenue (turnover) | £680k | £920k |
| Gross profit | £680k | £920k |
| Operating profit | £16.4k | £47.5k |
| Profit before tax | £16.4k | £47.5k |
| Profit after tax | £6.9k | £29.3k |
| Profit (best available) | £6.9k | £29.3k |
| Employees (average) | 1 | 3 |
| Ratios | ||
| Profit margin | 1% | 3.2% |
| Gross margin | 100% | 100% |
| Revenue per employee | £680k | £307k |
| Profit per employee | £6.9k | £9.8k |
| Growth (year on year) | ||
| Revenue growth | — | ▲35.4% |
| Profit growth | — | ▲328.1% |
| Headcount growth | — | ▲200% |
| Balance sheet — indirect signals, not revenue | ||
| Net assets | — | — |
| Source | Accounts · bulk data Nov 2025 | Accounts · bulk data Nov 2025 |
How the business works
- Profit margin
- 3.2%
- Profit ÷ revenue.
- Gross margin
- 100%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £307k
- Revenue ÷ average employees.
- Profit per employee
- £9.8k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- ▲200%
- Now 3
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Vanda Pharmaceuticals Inc. (registered outside the UK register)ultimate parent75–100%
- Vanda Pharmaceuticals Limitedthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Csa Catapult Services LimitedNewport · Other research and experimental development on natural sciences and engineering
- Revenue
- £875k
- Profit
- £22.6k
- Staff
- 2
- GT Diagnostics (UK) LimitedLondon · Other research and experimental development on natural sciences and engineering
- Revenue
- £712k
- Profit
- £42.3k
- Staff
- 3
- Rhoworld UK LtdCrawley · Other research and experimental development on natural sciences and engineering
- Revenue
- £1.3m
- Profit
- £21.5k
- Staff
- 9
- Jumo Europe LimitedLondon · Other research and experimental development on natural sciences and engineering
- Revenue
- £1.5m
- Profit
- £38.7k
- Staff
- 7
- Future Geoscience LtdWelshpool · Other research and experimental development on natural sciences and engineering
- Revenue
- £1.7m
- Profit
- £72.7k
- Staff
- 2
- Hessle Dock Company LimitedEast Yorkshire · Other research and experimental development on natural sciences and engineering
- Revenue
- £1.8m
- Profit
- £171k
- Staff
- 13
Sources
Latest figures from accounts for the year to 31 Dec 2024 (profit £29.3k), from the Companies House accounts bulk data published Nov 2025. Spotted an error? Request a correction.
Updated from Companies House on 12 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.